Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04878601
Other study ID # K01TW011484
Secondary ID K01TW011484
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 1, 2021
Est. completion date March 31, 2024

Study information

Verified date June 2023
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Men in Sub-Saharan Africa are less likely to test for HIV, initiate ART, and more likely to initiate ART at later stages of disease. Two overarching barriers keep HIV-positive men from accessing ART services: 1) Lack of male-friendly services, and 2) harmful gender norms. Home-based ART may improve ART initiation and retention among male partners who test HIV-positive through Index HIV self-testing (HIVST). We will pilot an intervention that provides home-based ART initiation and home-based continuation for 3-months, followed by assisted linkage to facility-based care at 4-months. 470 participants will be enrolled [209 females, 261 males]


Description:

Men in Sub-Saharan Africa are less likely to test for HIV, initiate ART, and more likely to initiate ART at later stages of disease. Achieving epidemic control requires immediate, concentrated effort to engage this largely unreached population. Index partner testing, whereby partners of HIV-positive clients are refereed for HIV testing, is critical to identifying undiagnosed men and has been adopted as a national policy by the Malawi Ministry of Health because of its high acceptability and its dramatic increase on HIV testing uptake. Two overarching barriers keep HIV-positive men from accessing ART services: 1) Lack of male-friendly services, and 2) harmful gender norms. Home-based ART may improve ART initiation and retention among male partners who test HIV-positive through Index HIVST. We will pilot an intervention that provides home-based ART initiation and home-based continuation for male partners identified as HIV-positive through Index HIVST for 3-months, followed by assisted linkage to facility-based care at 4-months. This intervention offers opt-out ART and in-depth, male-specific counseling for 3-months before linking men to facility based care. We will directly compare home-based ART to facility-based ART, whereby a health care worker will conduct a home-visit with HIV+ male partners to provide confirmatory HIV testing and immediate assisted linkage to a nearby facility for facility-based ART initiation and continuation.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 470
Est. completion date March 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years and older
Eligibility Female Partner Inclusion Criteria: - Male partner =15 years of age - No reported interpersonal violence (IPV) as defined by World Health Organization (WHO) with the above male partner in the past 12-months - Male partner ever tested HIV-positive - Male partner not currently engaged in ART services, defined as: - Tested HIV-positive =14 days and not on ART =14 days after testing HIV- positive; - =14 days late for the first four-week follow up appointment; or - Initiated ART but =60 days late for last ART appointment; - Male partner living inside the facility catchment area (defined as any area that Healthcare Workers (HCWs) from the study facility routinely visit for tracing purposes) Female Partner Exclusion Criteria: - Male partner <15 years of age - Reported interpersonal violence (IPV) as defined by WHO with the above male partner in the past 12-months - Male partner never tested HIV positive - Male partner tested HIV-positive <14 days ago - Male partner currently engaged in ART services, defined as: - Initiated ART <14 days late for the first four-week follow up appointment - Initiated ART and <60 days late for last ART appointment - Male partner living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes) Men Living with HIV Inclusion Criteria: - =15 years of age - Tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold) - Not currently engaged in ART services, defined as: - Tested HIV-positive =14 days and not on ART =14 days after testing HIV-positive; - =14 days late for the first four-week follow up appointment; or - Initiated ART but =60 days late for last ART appointment; - Has not taken ART in the past 7-days, as indicated by a point of care (POC) urine assay - Living inside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes) Men Living with HIV Exclusion Criteria: - <15 years of age - Never tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold) - Tested HIV-positive <14 days ago - Currently engaged in ART services, defined as: - Initiated ART - <14 days late for the first four-week follow up appointment - Initiated ART and <60 days late for last ART appointment - Has taken ART in the past 7-days, as indicated by a point of care (POC) urine assay - Living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Home-Based ART
Healthcare provider will ask ART client for permission to conduct a home visit with their HIV+ partner. Providers will conduct a home visit with HIV+ partners to provide confirmatory HIV testing and ART initiation with a 30-day supply. Monthly home-based ART follow-up visits with male-specific messaging and 30-day supply distribution will take place for 3-months. At 4-months providers will provide assisted linkage to a nearby facility to join the facility-based ART program. Additional counseling will be provided.
Facility-Based ART
Healthcare provider will ask ART client for permission to conduct a home visit with their HIV+ partner. Providers will conduct a home visit with HIV+ partners to provide confirmatory HIV testing and assisted linkage to a nearby facility for facility-based ART initiation and continuation. Male clients will receive a 30-day supply each visit and return monthly.

Locations

Country Name City State
Malawi Partners in Hope Lilongwe

Sponsors (3)

Lead Sponsor Collaborator
University of California, Los Angeles Fogarty International Center of the National Institute of Health, Partners in Hope, Malawi

Country where clinical trial is conducted

Malawi, 

Outcome

Type Measure Description Time frame Safety issue
Primary Men's ART Initiation ART initiation within 6-months of enrollment. Sourced from medical chart reviews. 6 months
Secondary Men's 6-month Retention 6-month retention (<60 days ever late for ART). Sourced from medical chart reviews. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2